Industry Updates & UBC News

- June 09, 2017
A leader in patient engagement across all aspects of drug development, access, and adherence, UBC has received seven awards for excellence in marketing and communications from two distinguished organizations. The Healthcare...
May is Lupus Awareness Month
Nicole Hebbert, VP, Patient Access & Engagement - May 25, 2017
The National Institutes of Health estimates more than 23 million Americans suffer from autoimmune disease, and that number is increasing every year.  Today, autoimmune diseases receive a significant amount of attention and new...
Tagged in:
Specialty Drugs Fill 2017 Pipeline
- May 04, 2017
New therapies to treat inflammatory conditions, multiple sclerosis, and cancer are among the products highlighted in Express Scripts’ Specialty Pipeline report. In 2016, specialty drugs made up 71% of the 24 drugs approved by the FDA...
Our EU risk management experts provide insights on the new EMA guidance.
Janine Collins, MBBS, LLM, Sr. Director, European Risk Management, and Dafna Bonneh-Barkay, PhD, MSc, Sr. Project Manager - April 03, 2017
Introduction On Friday, 31 March 2017 the EMA released the revised Module V- Risk Management Systems (Rev 2) of Good Pharmacovigilance Practice (GVP) (EMA/838713/2011 Rev 2) accompanied by a revised Guidance on the format of the...
Tagged in:
2017 pharmaceutical industry predictions
UBC - January 03, 2017
After weighing in on the biggest trends from the last year, we asked a few of our experts to predict the forces that would shape the industry in 2017. Optimizing the Value of Healthcare The focus of 2017 will be about realizing the...

Pages